Leveraging functional genomics to reveal novel targets for cancer treatment
Europese Commissie
Voor onderzoekers en artsen die nieuwe kankerbehandelingen willen ontwikkelen met behulp van genomica.
Ook bekend als HORIZON-MISS-2027-02-CANCER-01, HORIZON-MISS-2027-02, Supporting the implementation of the Cancer Mission
Waar is deze subsidie voor?
Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes: Researchers and health professionals gain a deeper understanding of the functional effects of tumour heterogeneity during cancer initiation and progression, supporting the identification of more precise and novel therapeutic targets. Researchers, health professionals and innovators benefit from improved knowledge and tools to support the discovery and development of next generation genomically-informed cancer treatments. Researchers, innovators, and professionals across disciplines and sectors contribute to the UNCAN.eu research data platform by ensuring data interoperability, and enabling sustainable access to newly developed digital tools and models for the analysis and management of multimodal clinical data. Scope: The proposed topic will contribute to the EU Cancer Mission objective of improving the understanding of cancer initiation and progression. Of particular interest for this topic are paediatric and adolescent cancers[1] , cancers with limited treatment options, refractory cancers, rare cancers or cancer types with low five-year survival rates. Proposals may include the design of exploratory mechanistic studies using longitudinal patient bio-samples, clinical proof-of-concept studies and/or observational and translational studies involving newly collected or existing data, as appropriate. Applica…
Voor wie is het bedoeld?
Voor onderzoekers en artsen die nieuwe kankerbehandelingen willen ontwikkelen met behulp van genomica.
Waarvoor kunt u subsidie krijgen?
- Kankeronderzoek genomica
- Nieuwe kankerbehandelingen
- Tumor heterogeniteit onderzoek
- Therapeutische targets ontdekking
Kom ik in aanmerking?
De eisen uit de regeling. Uw situatie bepaalt of u voldoet; dit is geen beschikking.
Openstellingen en rondes
- Start
- 10 feb 2027
- Sluit
- 21 sep 2027
- Budget
- -
- Verdeling
- Tender
Bronnen en actualiteit
“Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes: Researchers and health professionals gain a deeper understanding of the functional effects of tumour heterogeneity during cancer…”
Geen openbare bronnen beschikbaar.
Deze informatie is geautomatiseerd samengesteld uit officiële bronnen en kan onvolledig zijn. Controleer details bij de verstrekker. Elk hard feit toont een citaat uit de brontekst.